Celiac Disease autoantibodies targeted against transglutaminase 2: repercussions in vascular biology, disease pathogenesis and treatment

Project Information

TRANSVASCED

Grant agreement ID: 277049

Closed project

Start date 1 August 2011

End date 31 July 2014

Funded under

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 45 000,00

EU contribution € 45 000,00

Coordinated by

TAMPEREEN YLIOPISTO
Finland